ADMA Biologics

ADMA • NASDAQ • Stock Fundamentals

ADMA Biologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adam S. Grossman, with a market cap of $1.9B.

Market Cap$1.9B

Employees624.0

CEOAdam S. Grossman

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about ADMA Biologics

ADMA Biologics (ADMA) has a market capitalization of $1.9B and trades on NASDAQ.

ADMA Biologics has approximately 624 employees.